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Summary
Background/aims: Cerebrovascular ultrasonography was useful clinically for evaluating cerebral
hemodynamics rapidly and in real-time for patients with acute ischemic stroke. We analyzed if
the patients had early recanalization or not using transcranial color-coded sonography (TCCS)
in order to evaluate the usefulness of real-time monitoring in systemic thrombolysis.
Methods: Subjects were patients who had acute ischemic stroke with intravenous tissue plas-
minogen activator (tPA) within 3 h from onset. We evaluated occlusion of intracranial arteries
from transtemporal or suboccipital window by TC-CFI with Thrombolysis in Brain Ischemia (TIBI)
ﬂow-grading system and monitored residual ﬂow in real-time every 15min until 120min after
the t-PA bolus.
Results: We could monitor residual ﬂow in 5 patients who had good echo windows (4 male, mean
age; 60.8± 6.4 years). Two patients had proximal occlusion of the middle cerebral artery (MCA),
one patient had distal occlusion of MCA, one patient had M2 occlusion and one patient had distal
occlusion of unilateral vertebral artery. Four patients had early complete recanalization within
60min after the t-PA bolus (two patients within 60min and other two patients within 30min),
however, occlusion persisted during 120min monitoring in one patient with proximal occlusion
of MCA. NIH Stroke Scale of two patients with very early recanalization was 0 at the end of the
treatment. There was no symptomatic and asymptomatic intracranial hemorrhage in 4 patients
except for the patients without recanalization.
Conclusions: It is anticipated that real-time ultrasound monitoring is useful for evaluating a
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howed that intravenous thrombolysis with acute ischemic
troke within 3 h from onset had favorable clinical recov-
ry compared with placebo-treated patients [1]. However,
thrombolytic effect was not evaluated with monitoring
s under CC BY-NC-ND license.f occlusion artery in this study. Cerebrovascular ultra-
onography was useful clinically for evaluating cerebral
emodynamics rapidly and in real-time for the patients with
cute ischemic stroke compared with magnetic resonance
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ngiography (MRA). The timing and speed of recanalization
fter (tPA) therapy monitoring by transcranial Doppler (TCD)
orrelates with clinical recovery [2,3]. These real-time ﬂow
nformations are useful in developing next therapies and in
election for interventional treatment.
The aim of this study was to analyze if the patients had
arly recanalization or not using transcranial color-coded
onography (TCCS) in order to evaluate the usefulness of
eal-time monitoring in systemic thrombolysis.
aterial and methods
onsecutive patients who had acute ischemic stroke with
ntravenous tPA within 3 h from onset between April 2010
nd January 2011 were included in this study. tPA was admin-
stered in a dose of 0.6mg/kg (10% bolus, 90% continuous
nfusion during 1 h) according to Japanese standard proto-
ol [4]. The patients with insufﬁcient acoustic window were
xcluded.
An experienced neuro-sonographer performed all TCCS
tudies using a EUB-7500 or 8500 with a 2MHz sector trans-
ucer (S50A, HITACHI Medical Corporation, Japan). We eval-
ated occlusion of intracranial arteries from transtemporal
r suboccipital window by TCCS with Thrombolysis in Brain
schemia (TIBI) ﬂow-grading system [5] and monitored resid-
al ﬂow in real-time every 15min until 120min after the t-PA
olus. An insonation time with TCCS was not longer than
min in each examination. No head frame was used during
nsonation. Complete recanalization was deﬁned as TIBI 0—3
o 5, and partial recanalization was deﬁned as TIBI 0—2 to 3.
National Institutes of Health Stroke Scale (NIHSS) scores
ere obtained before tPA treatment, every 15min until 1 h
nd every 30min after 1 h by a neurologist. Dramatic clinical
ecovery was deﬁned as a decrease in the total NIHSS score
o <3 at the end of tPA infusion.
All patients had magnetic resonance imaging (MRI)
ncluding diffusion-weighted imaging (DWI) and MRA before
D
T
i
Table 1 Clinical data of subjects.
Case Age Sex TIBI MRA Early
recana
1 68 M TIBI 3 at Rt M1 Rt M1 distal
occlusion
Compl
2 58 M TIBI 3 at Rt VA Rt VA distal
occlusion
Compl
3d 52 M TIBI 3 at Lt M1 Lt M2 occlusion Compl
4d 60 F TIBI 0 at Rt M2 Rt M1 proximal
occlusion
M2a; p
M2b;
compl
5 66 M TIBI 0 at Lt M1 Lt M1 proximal
occlusion
No
recana
M, male; F, female; Rt, right; Lt, left; VA, vertebral artery; ICH, intrac
Case 4; one branch of M2 had complete recanalization < 30min, the
recanalization at 120min.
a Recanalization < 60min.
b Recanalization < 30min.
c NIHSS at 120.
d Two patients with gray shaded values had very early recanalizationH. Mitsumura et al.
PA administration. Follow-up MRA was performed immedi-
tely after the end of tPA infusion, if possible.
esults
e could monitor residual ﬂow in 5 patients who had good
cho windows (4 male, mean age; 60.8± 6.4 years). Two
atients had proximal occlusion of the middle cerebral
rtery (MCA), one patient had distal occlusion of the MCA,
ne patient had a M2 occlusion and one patient had a distal
cclusion of the unilateral vertebral artery. One patient with
roximal MCA occlusion had an insufﬁcient acoustic window,
ut we could monitor residual ﬂow at M2.
Four patients had early complete recanalization within
0min after the t-PA bolus - two patients at 60min and other
wo patients at 30min. In the patient who could be moni-
ored at M2, one of M2 (M2a) was partial at 30min, another
2 (M2b) was complete at 30min. On the other hand, the
cclusion persisted during 120min monitoring in one patient
ith proximal occlusion of MCA.
NIH Stroke Scale of two patients with very early recanal-
zation (within 30min) was 0 at the end of the treatment
dramatic clinical recovery).
In three patients a follow-up MRA could be performed
fter the end of tPA infusion. Follow-up MRA showed early
ecanalization in two patients and no recanalization in one
atient. These ﬁndings of MRA were consistent with diagno-
is of TCCS. There was no symptomatic and asymptomatic
ntracranial hemorrhage in 4 patients except for the patients
ithout recanalization. Table 1 shows clinical detail data of
patients, and Fig. 1 shows the information of TCCS und MRA
n patients with very early recanalization (within 30min).iscussion
he present study showed that patients with early recanal-
zation had a favorable outcome after tPA therapy. In these
lization
NIHSS
before
treatment
NIHSS after
treatmentc
Symptomatic
ICH
etea 10 6 −
etea 4 2 −
eteb 2 0 −
artial
eteb
10 0 −
lization
18 19 +
erebral hemorrhage.
other branch had partial recanalization at 30min and complete
(within 30min). Details are shown in Fig. 1.
Evaluation of very early recanalization after tPA administration 333
Figure 1 Angiographic information of patients with very early recanalization (see also case 3 and case 4 on table). Upper table is
sonogram of residual ﬂow and NIHSS at each examination point. Lower pictures are MRA before and after tPA therapy. Case 3 was
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[7] Kimura K, Iguchi Y, Shibasaki K, Aoki J, Watanabe M, Kobayashi
K, et al. Recanalization within one hour after intravenous tissue
plasminogen activator is associated with favorable outcome inM2 occlusion and case 4 with proximal MCA occlusion had insuf
Case 3 had very early complete recanalization within 30min aft
and another M2 (M2b) was complete at 30min. MRA ﬁndings of
studies, recanalization after tPA was evaluated by MRA [6,7]
or TCD [2,3]. There are different beneﬁts and limitations
between MRA and TCD/TCCS in their diagnostic ability and
characteristics as a diagnostic device. MRI is the standard
device for the detection of vessel occlusion or stenosis, how-
ever, it cannot be monitored during tPA infusion because
patients who get a MRI have to be transferred to the MRI
laboratory. On the other hand, TCD/TCCS is useful for real-
time evaluation of intracranial hemodynamics at patient’s
bedside. Several cases, however, had an insufﬁcient acoustic
window especially in Asian elderly female.
In TCD study (2), 25% patients recanalized within the
ﬁrst 30min, 50% recanalized within 30—60min, 11% recanal-
ized 61—120min, and 14% recanalized after ﬁrst 2 h after
tPA bolus administration. The timing of arterial recanaliza-
tion after stroke onset detected with TCD correlated with
early improvement in the NIHSS scores within the next hour
after recanalization (S-shaped curve demonstrates corre-
lation between timing of recanalization on TCD and early
recovery from ischemic stroke).
Our data showed patients with complete early recov-
ery after tPA treatment recanalized within the ﬁrst 30min
on TCCS monitoring. It is anticipated that early arterial
recanalization correlated with early clinical improvement
like present studies.
In other TCD study (3), the speed of intracranial arterial
recanalization on TCD correlates with short-term improve-
ment after tPA therapy. Short duration (sudden < 1min and
stepwise 1—29min) of arterial recanalization is associated
with better short-term improvement because of faster and
more complete clot breakup with low resistance of the dis-
tal circulatory bed. Slow (>30min) ﬂow improvement and
dampened ﬂow signal that indicate partial recanalization
are less favorable prognostic signs.
However, our study did not use continuous TCCS moni-
toring, the speed of clot lysis as well as timing of arterial
recanalization is useful information for evaluating effect of
thrombolytic therapy. This real-time and noninvasive infor-
mation using TCD/TCCS are the advantage over MRA.t acoustic window, but we could monitor residual ﬂow at M2.
e t-PA bolus. In case 4, one of M2 (M2a) was partial at 30min,
cases were consistent with diagnosis of TCCS.
onclusions
ery early recanalization within 30min after tPA administra-
ion correlated with complete early on TCCS monitoring. It
s anticipated that real-time ultrasound monitoring is useful
or evaluating very early thrombolytic effect of tPA con-
ected with early clinical recovery.
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